Načítá se...
Psoriasis Induced by Trastuzumab (Herceptin®)
Trastuzumab (Herceptin), a humanized monoclonal antibody, is a cancer drug developed to target the human epidermal receptor (HER) 2, which is overexpressed in some cancer cells. Cutaneous side effects, such as folliculitis, xerosis, and alopecia have not been reported with therapies targeting HER2,...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3662920/ https://ncbi.nlm.nih.gov/pubmed/23717018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2013.25.2.229 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|